306 related articles for article (PubMed ID: 21263443)
1. APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921.
Schiepers OJ; Harris SE; Gow AJ; Pattie A; Brett CE; Starr JM; Deary IJ
Mol Psychiatry; 2012 Mar; 17(3):315-24. PubMed ID: 21263443
[TBL] [Abstract][Full Text] [Related]
2. MTHFR polymorphisms and cognitive ageing in the ninth decade: the Lothian Birth Cohort 1921.
Schiepers OJ; van Boxtel MP; Harris SE; Gow AJ; Pattie A; Brett CE; de Groot RH; Jolles J; Starr JM; Deary IJ
Genes Brain Behav; 2011 Apr; 10(3):354-64. PubMed ID: 21255267
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.
Caselli RJ; Reiman EM; Osborne D; Hentz JG; Baxter LC; Hernandez JL; Alexander GG
Neurology; 2004 Jun; 62(11):1990-5. PubMed ID: 15184602
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein e gene variability and cognitive functions at age 79: a follow-up of the Scottish mental survey of 1932.
Deary IJ; Whiteman MC; Pattie A; Starr JM; Hayward C; Wright AF; Visscher PM; Tynan MC; Whalley LJ
Psychol Aging; 2004 Jun; 19(2):367-71. PubMed ID: 15222832
[TBL] [Abstract][Full Text] [Related]
7. Cognitive ability at age 11 and 70 years, information processing speed, and APOE variation: the Lothian Birth Cohort 1936 study.
Luciano M; Gow AJ; Harris SE; Hayward C; Allerhand M; Starr JM; Visscher PM; Deary IJ
Psychol Aging; 2009 Mar; 24(1):129-38. PubMed ID: 19290744
[TBL] [Abstract][Full Text] [Related]
8. Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample.
Liu X; Beck T; Dhana K; Tangney CC; Desai P; Krueger K; Evans DA; Rajan KB
J Nutr Health Aging; 2024 May; 28(5):100211. PubMed ID: 38507884
[TBL] [Abstract][Full Text] [Related]
9. Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.
Ma F; Wang J; Miao R; Zhao W; Wang Q
Neuropsychobiology; 2011; 64(2):102-9. PubMed ID: 21701228
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants.
Lyall DM; Ward J; Ritchie SJ; Davies G; Cullen B; Celis C; Bailey ME; Anderson J; Evans J; Mckay DF; Mcintosh AM; Sattar N; Smith DJ; Deary IJ; Pell JP
Age Ageing; 2016 Jul; 45(4):511-7. PubMed ID: 27103599
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal modeling of cognitive aging and the TOMM40 effect.
Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
[TBL] [Abstract][Full Text] [Related]
12. Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study.
Zou H; Luo S; Liu H; Lutz MW; Bennett DA; Plassman BL; Welsh-Bohmer KA
J Prev Alzheimers Dis; 2023; 10(4):886-894. PubMed ID: 37874111
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E genotype and memory in the sixth decade of life.
Schultz MR; Lyons MJ; Franz CE; Grant MD; Boake C; Jacobson KC; Xian H; Schellenberg GD; Eisen SA; Kremen WS
Neurology; 2008 May; 70(19 Pt 2):1771-7. PubMed ID: 18235080
[TBL] [Abstract][Full Text] [Related]
14. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW
Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E is not related to memory abilities at 70 years of age.
Luciano M; Gow AJ; Taylor MD; Hayward C; Harris SE; Campbell H; Porteous DJ; Starr JM; Visscher PM; Deary IJ
Behav Genet; 2009 Jan; 39(1):6-14. PubMed ID: 18946731
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
17. Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains.
Smits LL; Pijnenburg YA; van der Vlies AE; Koedam EL; Bouwman FH; Reuling IE; Scheltens P; van der Flier WM
Eur Neuropsychopharmacol; 2015 Jul; 25(7):1010-7. PubMed ID: 25891378
[TBL] [Abstract][Full Text] [Related]
18. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging.
Hayden KM; McEvoy JM; Linnertz C; Attix D; Kuchibhatla M; Saunders AM; Lutz MW; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
Alzheimers Dement; 2012 Sep; 8(5):381-8. PubMed ID: 22863908
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and neural signatures of the APOE E4 allele in mid-aged adults.
Evans S; Dowell NG; Tabet N; Tofts PS; King SL; Rusted JM
Neurobiol Aging; 2014 Jul; 35(7):1615-23. PubMed ID: 24582638
[TBL] [Abstract][Full Text] [Related]
20. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
